Dow Up1.32% Nasdaq Up1.60%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
54.05 2.61(5.07%) Oct 23, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   13,625   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   13,625   -   -  
Operating Expenses
Research Development28,440  24,151  22,544  16,063  
Selling General and Administrative6,126  6,142  5,950  4,312  
Non Recurring400  8,406   -   -  
Others -  3,409   -   -  
Total Operating Expenses -  42,108   -   -  
Operating Income or Loss (34,966) (28,483) (28,494) (20,375)
Income from Continuing Operations
Total Other Income/Expenses Net270  (106)(657)55  
Earnings Before Interest And Taxes(34,696)(28,589)(29,151)(20,320)
Interest Expense -   -   -   -  
Income Before Tax(34,696)(28,589)(29,151)(20,320)
Income Tax Expense68  2,129  52   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(34,764)(30,718)(29,203)(20,320)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (34,764) (30,718) (29,203) (20,320)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (34,764) (30,718) (29,203) (20,320)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.